Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seiler

Showing results (251-260 of 274) with videos related to

Pageof 28
Sort By:
Nature Physics|December 15, 2025
Hybrid Frenkel-Wannier excitons facilitate ultrafast energy transfer at a 2D-organic interfaceWiebke Bennecke, Ignacio Gonzalez Oliva, Jan Philipp Bange, et al.
ALTEX|August 16, 2012
Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluationAnna K Bal-Price, Sandra Coecke, Lucio Costa, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Karen S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis of potent and highly selective inhibitors of human tryptaseWilliam A Slusarchyk, Scott A Bolton, Karen S Hartl, et al.
Leukemia|September 9, 2016
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblastsA Mupo, M Seiler, V Sathiaseelan, et al.
Physical Review Letters|May 22, 2026
Role of Nonequilibrium Populations in Dark-Exciton FormationPaul Werner, Wiebke Bennecke, Jan Philipp Bange, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664Jagabandhu Das, S David Kimball, Steven E Hall, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Pageof 28

Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Nature Physics|December 15, 2025
Hybrid Frenkel-Wannier excitons facilitate ultrafast energy transfer at a 2D-organic interfaceWiebke Bennecke, Ignacio Gonzalez Oliva, Jan Philipp Bange, et al.
ALTEX|August 16, 2012
Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluationAnna K Bal-Price, Sandra Coecke, Lucio Costa, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Karen S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis of potent and highly selective inhibitors of human tryptaseWilliam A Slusarchyk, Scott A Bolton, Karen S Hartl, et al.
Leukemia|September 9, 2016
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblastsA Mupo, M Seiler, V Sathiaseelan, et al.
Physical Review Letters|May 22, 2026
Role of Nonequilibrium Populations in Dark-Exciton FormationPaul Werner, Wiebke Bennecke, Jan Philipp Bange, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664Jagabandhu Das, S David Kimball, Steven E Hall, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Pageof 28